Skip to main content

editorial

. 2009 Nov 12;32(10):597. doi: 10.1002/clc.20670

Spironolactone Therapy in Heart Failure Patients with Chronic Kidney Disease

Ricardo Lopes ^1,^✉, Patricia Lourenco ², Joana Mascarenhas ², Ana Azevedo ², Paulo Bettencourt ²

PMCID: PMC6653212 PMID: 19911355

Full Text

The Full Text of this article is available as a PDF (38.9 KB).

References

1. Kandula P, Sham R. Safety of spironolactone use in ambulatory heart failure patients. Clin Cardiol 2009; 32(6): 347–348. [DOI] [PMC free article] [PubMed] [Google Scholar]
2. Lopes RJ, Lourenço AP, Mascarenhas J, Azevedo A, Bettencourt P. Safety of spironolactone use in ambulatory heart failure patients. Clin Cardiol. 2008; 31(11): 509–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
3. Wencker D. Acute cardio‐renal syndrome: progression from congestive heart failure to congestive kidney failure. Curr Heart Fail Rep 2007; 4(3): 134–138. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES